Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Rao Mulpuri, Andrzej Jakubowiak, Shaji Kumar, Sagar Lonial, and More

Premium

Provista Diagnostics, a developer of proteomics-based cancer tests, has appointed Rao Mulpuri as COO. Most recently Mulpuri was VP of lab operations for Assurex Health, and he has held various leadership positions at Catholic Health Initiatives Center for Translational Research, Beckman Coulter Genomics, and Cogenics.


Dutch molecular diagnostics company SkylineDx picked members of its scientific advisory board.

SkylineDx's newly formed SAB include Andrzej Jakubowiak, a professor of medicine and director of the University of Chicago's myeloma program; Shaji Kumar, a professor of medicine at the Mayo Clinic College of Medicine; Sagar Lonial, a trained bone marrow transplant physician with an interest in molecular therapy for lymphoma and myeloma; Gareth Morgan, director of the Myeloma Institute at the University of Arkansas for Medical Sciences; Antonio Palumbo, chief of the myeloma unit of the department of oncology at the University of Torino in Italy; David Siegel, chief of the division of multiple myeloma at Hackensack University Medical Center; Pieter Sonneveld, head of the department of hematology at Erasmus MC; and Keith Stewart, dean for research at the Mayo Clinic in Arizona.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.